KURA 241115 17.50P (KURA241115P17500) Stock Options, News & Quotes

US OptionsDetailed Quotes

KURA241115P17500

Watchlist

1.00
0.000.00%

15min DelayClose Oct 30 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus
Seeking AlphaOct 24 15:32 ET
Express News | Kura Oncology Inc - Proof-of-Concept Study of Ziftomenib Plus Imatinib to Begin in 1H 2025
ReutersOct 24 07:30 ET
Express News | Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (Gist)
ReutersOct 24 07:30 ET
H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $32
Moomoo NewsOct 24 06:31 ET · Ratings
UBS Initiates Kura Oncology(KURA.US) With Buy Rating, Announces Target Price $27
Moomoo NewsOct 24 06:31 ET · Ratings
Kura Oncology to Present New Data Supporting Combination of KO-2806 With KRAS G12C and Pan-RAS Inhibitors
GlobeNewswireOct 23 07:30 ET

Comments

Teddy123

Sep 30 23:29

Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology

$Kura Oncology (KURA.US)$
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology | KURA Stock News

J Lim - TTP

Mar 7 07:51

I like the g/up base with low vol, especially after earnings. High RS98.
$Kura Oncology (KURA.US)$

Kura Oncology(KURA) Pre-Mkt Price 23.160 +2.03%

Bigmoney Dreamer

Jan 24 09:11

$Kura Oncology (KURA.US)$ halt ?

Moomoo AI

Oct 11, 2023 07:42

Insider selling at Kura Oncology with no purchases in past year could concern investors. More ideally, insider ownership percentage would be higher. Yet, implications aren't set in stone, consider other company-specific risks.

Kura Oncology Repeat Insider Selling Not A Positive Indicator

Alvinnnnnnngenius

Dec 12, 2022 08:34

Halt down

$Kura Oncology (KURA.US)$